Dr. Reddy's Laboratories Ltd. (RDY)
12.25
0.00 (0.00%)
USD |
NYSE |
Oct 02, 16:00
12.26
0.00 (0.00%)
After-Hours: 20:00
Dr. Reddy's Laboratories Price to Book Value : 2.519 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.519 |
| October 01, 2026 | 2.519 |
| September 30, 2026 | 2.595 |
| September 29, 2026 | 2.642 |
| September 28, 2026 | 2.573 |
| September 25, 2026 | 2.519 |
| September 24, 2026 | 2.529 |
| September 23, 2026 | 2.548 |
| September 22, 2026 | 2.585 |
| September 21, 2026 | 2.55 |
| September 18, 2026 | 2.507 |
| September 17, 2026 | 2.507 |
| September 16, 2026 | 2.402 |
| September 15, 2026 | 2.375 |
| September 14, 2026 | 2.449 |
| September 11, 2026 | 2.447 |
| September 10, 2026 | 2.408 |
| September 09, 2026 | 2.443 |
| September 08, 2026 | 2.443 |
| September 04, 2026 | 2.462 |
| September 03, 2026 | 2.474 |
| September 02, 2026 | 2.503 |
| September 01, 2026 | 2.503 |
| August 31, 2026 | 2.494 |
| August 28, 2026 | 2.505 |
| Date | Value |
|---|---|
| August 27, 2026 | 2.501 |
| August 26, 2026 | 2.513 |
| August 25, 2026 | 2.538 |
| August 24, 2026 | 2.513 |
| August 21, 2026 | 2.505 |
| August 20, 2026 | 2.490 |
| August 19, 2026 | 2.490 |
| August 18, 2026 | 2.499 |
| August 17, 2026 | 2.490 |
| August 14, 2026 | 2.523 |
| August 13, 2026 | 2.554 |
| August 12, 2026 | 2.548 |
| August 11, 2026 | 2.560 |
| August 10, 2026 | 2.499 |
| August 07, 2026 | 2.513 |
| August 06, 2026 | 2.490 |
| August 05, 2026 | 2.496 |
| August 04, 2026 | 2.488 |
| August 03, 2026 | 2.482 |
| July 31, 2026 | 2.437 |
| July 30, 2026 | 2.433 |
| July 29, 2026 | 2.418 |
| July 28, 2026 | 2.412 |
| July 27, 2026 | 2.420 |
| July 24, 2026 | 2.424 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 1.214 |
| Teva Pharmaceutical Industries Ltd. | 5.94 |
| Novo Nordisk A/S | 4.875 |
| AstraZeneca PLC | 10.28 |
| ANI Pharmaceuticals, Inc. | 2.776 |
Price to Book Value Related Metrics
| PE Ratio | 27.53 |
| PS Ratio | 2.791 |
| Price to Free Cash Flow | 134.26 |
| Price | 12.25 |
| Earnings Yield | 3.63% |
| Market Cap | 10.20B |
| Operating PE Ratio | 27.70 |